Pricing Log in Create free account

Azitra, Inc. (AZTR) vs Nuvilex Inc. (PMCB)

Azitra, Inc. and Nuvilex Inc. are both Biotechnology companies. Azitra, Inc. and Nuvilex Inc. are of similar size ($4.4M and $4.0M). Nuvilex Inc. has negative trailing earnings, so its P/E is not meaningful; Azitra, Inc. trades at 1.3×. Azitra, Inc. grew revenue faster over the last twelve months: 58.2% against −71.1%. Across the 12 metrics below, Azitra, Inc. leads on 6 and Nuvilex Inc. on 6.

Valuation

Metric AZTR PMCB Biotechnology median
P/E 1.27 n/m 10.60
P/S 2.50 n/m 9.40
P/B 0.20 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.47 3.77 0.66
EV/Sales (9.10) n/m 9.02
Earnings yield 78.60% (650.59%) (32.88%)
Free cash flow yield (786.51%) (266.52%) (23.13%)

Profitability

Metric AZTR PMCB Biotechnology median
Gross margin 100.00% 95.64% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) (58.04%) (51.96%)
Return on assets (190.69%) (50.43%) (46.06%)
Return on invested capital (1,272.49%) 0.00% 0.00%

Growth

Metric AZTR PMCB Biotechnology median
Revenue growth (TTM) 58.18% (71.06%) 6.76%
EPS growth (last fiscal year) 85.68% (186.83%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 40.29 4.97
Net debt to EBITDA 0.20 5.41 1.01

Dividend

Metric AZTR PMCB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZTR PMCB Biotechnology median
Market cap 4.39m 4.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack